Bioequivalence Study of Revolade® Eltrombopag 50 mg
Clinical trial NCT06834451 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06834451
- Sponsor
- Centro de Atencion e Investigacion Medica
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-01
- Primary completion
- 2025-10-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.